Thomas S. Clement
Keine laufenden Positionen mehr
Profil
Thomas S.
Clement worked as a Quality Manager at Biotech Research Labs, Inc. from 1984 to 1988.
He then worked as a Manager-Regulatory Affairs at Amersham Corp.
in 1989.
From 1989 to 2002, he worked as a Director-Regulatory Affairs at Organon Teknika Corp.
LLC.
Later, he worked as a Vice President-Quality & Regulatory Affairs at Roche Molecular Systems, Inc. from 2002 to 2008.
In 2009 to 2011, he worked as a VP-Global Regulatory & Clinical Affairs at QIAGEN NV.
He also worked as a Vice President-Regulatory & Quality Affairs at LipoScience, Inc. Mr. Clement completed his undergraduate degree from the University of Maryland.
Ehemalige bekannte Positionen von Thomas S. Clement
| Unternehmen | Position | Ende |
|---|---|---|
| QIAGEN N.V. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2011 |
Roche Molecular Systems, Inc.
 Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | General Counsel | 01.01.2008 |
Organon Teknika Corp. LLC
 Organon Teknika Corp. LLC Financial ConglomeratesFinance Part of Merck & Co., Inc., Organon Teknika Corp. LLC is an American company led by the management of PerImmune. | General Counsel | 01.01.2002 |
Amersham Corp.
 Amersham Corp. Investment ManagersFinance Founded in 1993 by Andrew Cousin, Amersham Corp. is a private equity firm located in Louisville, Colorado with additional offices in California, Florida, Texas and China. | General Counsel | 01.01.1989 |
| Biotech Research Labs, Inc. | Corporate Officer/Principal | 01.01.1988 |
Ausbildung von Thomas S. Clement
| University of Maryland | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| QIAGEN N.V. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
LipoScience, Inc.
 LipoScience, Inc. Medical SpecialtiesHealth Technology LipoScience, Inc. develops and markets medical applications of Nuclear Magnetic Resonance. The firm provides advanced patient care for the patients who are suffering from cardiovascular, metabolic and other related diseases. The company was founded by James D. Otvos, Stephen K. Markham, and Richard A. Franco, Sr. and is headquartered in Raleigh, NC. | Health Technology |
Roche Molecular Systems, Inc.
Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | Health Services |
Organon Teknika Corp. LLC
Organon Teknika Corp. LLC Financial ConglomeratesFinance Part of Merck & Co., Inc., Organon Teknika Corp. LLC is an American company led by the management of PerImmune. | Finance |
Amersham Corp.
Amersham Corp. Investment ManagersFinance Founded in 1993 by Andrew Cousin, Amersham Corp. is a private equity firm located in Louisville, Colorado with additional offices in California, Florida, Texas and China. | Finance |
| Biotech Research Labs, Inc. | Miscellaneous |
